Nuvectis Pharma, Inc. (NVCT) Misses Q3 EPS by 3c

Nuvectis Pharma, Inc. (NASDAQ: NVCT) reported Q3 EPS of ($0.37), $0.03 worse than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Nuvectis Pharma, Inc. (NVCT) click here.

You May Also Be Interested In

• Wells Fargo cuts Netflix rating on engagement risk, weak slate
• Lucid Capital Markets Starts Bain Capital Specialty Finance (BCSF) at Neutral
• Inhibrx Biosciences (INBX) Reiterated at Market Perform by Citizens on INBRX-106 Ph2 Results